These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 201940)

  • 1. Possible role of dopamine-beta-hydroxylase in the regulation of norepinephrine biosynthesis in rat brain.
    Wise CD; Belluzzi JD; Stein L
    Pharmacol Biochem Behav; 1977 Dec; 7(6):549-53. PubMed ID: 201940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes.
    Schlichter D; Da Prada M; Pletscher A
    Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine.
    Evans KR; Beninger RJ; Eikelboom R
    Pharmacol Biochem Behav; 1985 Apr; 22(4):535-40. PubMed ID: 3991764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland.
    Blaustein JD; Brown TJ; McElroy JF
    Neuroendocrinology; 1986; 43(2):143-9. PubMed ID: 2873523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of various inhibitors of tyrosine hydroxylase and dopamine beta-hydroxylase on rat self-stimulation after reserpine treatment.
    Stinus L; Thierry AM; Cardo B
    Psychopharmacologia; 1976 Feb; 45(3):287-94. PubMed ID: 2944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of variations in adrenocortical function on dopamine beta-hydroxylase and norepinephrine in the brain of the rat.
    Shen JT; Ganong WF
    J Pharmacol Exp Ther; 1976 Dec; 199(3):639-48. PubMed ID: 994021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of psychotropic drugs and the roles of the noradrenergic and dopaminergic systems in the lateral hypothalamic self-stimulation behavior].
    Hasegawa K; Sakai U
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):815-26. PubMed ID: 1035185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of two inhibitors of dopamine beta-hydroxylase on maturation of memory in mice.
    Flexner JB; Flexner LB
    Pharmacol Biochem Behav; 1976 Aug; 5(2):117-21. PubMed ID: 996046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic role in the self-administration of morphine or amphetamine.
    Davis WM; Smith SG; Khalsa JH
    Pharmacol Biochem Behav; 1975; 3(3):477-84. PubMed ID: 168592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachycardia in spontaneously hypertensive and normotensive rats after fusaric acid and bupicamide.
    Antonaccio MJ; Coté D; Cavaliere T
    Clin Exp Pharmacol Physiol; 1976; 3(3):199-206. PubMed ID: 975616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Roles of noradrenergic and dopaminergic systems in the self-stimulation behavior of the substantia nigra].
    Hasegawa K
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):827-35. PubMed ID: 1035186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The direct converstion of dopamine 3-O-sulfate to norepinephrine by dopamine-beta-hydroxylase.
    Buu NT; Kuchel O
    Life Sci; 1979 Feb; 24(9):783-9. PubMed ID: 571950
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine-beta-hydroxylase inhibitors modulate the concentration of functional estrogen receptors in female rat hypothalamus and pituitary gland.
    Blaustein JD; Brown TJ; Swearengen ES
    Neuroendocrinology; 1986; 43(2):150-8. PubMed ID: 3014364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral depression: thyroid interactions with norepinephrine-depleting drugs.
    Davenport JW; Hennies RS; Carey JC; Bishop SB
    Pharmacol Biochem Behav; 1976 Jul; 5(1):87-9. PubMed ID: 186817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):293-308. PubMed ID: 34468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-beta-hydroxylase inhibition acutely stimulates rats hypothalamic noradrenaline and dopamine neuronal activity as assessed from metabolic ratios and circulating glucose and ACTH responses.
    Smythe GA; Bradshaw JE; Gleeson RM; Nicholson MV
    Life Sci; 1985 Sep; 37(9):841-7. PubMed ID: 2993777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopamine-beta-hydroxylase inhibitors FLA-57 and FLA-63 on ethanol metabolism and aldehyde dehydrogenase activity in rats.
    Tottmar O; Hellström E; Holmberg K; Lindros KO
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):198-202. PubMed ID: 7136724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of epinine formation in adrenal medulla and brain of rats during cold exposure and inhibition of dopamine beta-hydroxylase.
    Schümann HJ; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 1976 May; 293(2):139-44. PubMed ID: 958503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylase.
    Botwinick CY; Quartermain D; Freedman LS; Hallock MF
    Pharmacol Biochem Behav; 1977 May; 6(5):487-91. PubMed ID: 19771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.